Responding to Criticism of ‘State Pharmaceutical Importation Programs Threaten Patients and Innovation’
A recent article by Dr. Kristina M. L. Acri née Lybecker highlighted her research about the fiscal workability of state pharmaceutical importation programs. The comments on the article elicited some common myths about Canadian drug importation that are important to address.